Israel’s Sol-Gel (reported here previously) has had its Twyneo acne treatment US FDA-approved following successful Phase 3 testing. https://ir.sol-gel.com/news-releases/news-release-details/sol-gel-technologies-announces-fda-acceptance-filing-new-drug-0

Following on from good Phase 2 trials (see here) Israel’s Sol-Gel reported excellent results from pivotal Phase 3 clinical trials of its Twyneo treatment of patients with acne vulgaris. The trial significantly reduced moderate-to-severe acne in 858 patients aged nine … Continue reading →

Israeli biotech Sol-Gel has announced positive interim results in its Phase II clinical trial for its “Twin” treatment for acne. “Twin” combines two known acne treatments with a unique method of molecular wrapping that makes it easier to penetrate the … Continue reading →